<DOC>
	<DOCNO>NCT02002897</DOCNO>
	<brief_summary>The study aim evaluate efficacy fractional carbon dioxide laser new modality treatment localize scleroderma compare result well establish method UVA 1 phototherapy .</brief_summary>
	<brief_title>Fractional Carbon Dioxide Laser Versus UVA 1 Treatment Localized Scleroderma</brief_title>
	<detailed_description>The study include 20 Cases present one lesion morphea ( plaque , linear atrophic ) . Each case subject : 1 . -Informed consent . 2-Detailed history 3- Clinical examination ass type , site , extent . 4-Clinical evaluation treatment , follow period treatment ( 24 session UVA1 ) ( one month last CO2 laser session ) use score system : - Skin thickness : 0-3 , 0 : normal ; 1 : thicken skin ; 2 : decrease ability move skin ; 3 : unable pinch move skin ( accord Modified Rodnan skin score ) - Dermal atrophy : 0-3 , 0 : none , 1 : shiny , 2 : visible vessel , 3 : obvious atrophy - Dyspigmentation ( Hypo hyper pigmentation ) : 0-3 , 0 : none , 1 : mild , 2 : moderate ,3 : mark C- Digital Photography , follow treatment use digital camera , fix distance constant setting standardization . 5-Investigations : A- Punch biopsy : A punch biopsy take treatment stain haematoxylin eosin . B-Immunohistochemical assessment - MMP1 ( matrix metalloproteinase 1 ) pre post treatment skin biopsy . - TGFÃŸ ( transform growth factor beta ) pre post treatment skin biopsy . 6-Treatment intervention : Two lesion identical score choose treatment intervention . 1 . Lesion number ( 1 ) subject : localize UVA1 phototherapy ( 340-400 nm ) , low dose irradiation , rate 3 session per week , total 24 session full clinical evaluation investigation treatment clinical follow one month treatment . 2 . Lesion number ( 2 ) subject : Fractional carbon dioxide laser ( 10,600 nm ) , session per month , total 3 session full clinical evaluation investigation one month last session treatment .</detailed_description>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Scleroderma , Localized</mesh_term>
	<criteria>1 . Types morphea : plaque , linear atrophic . 2 . Patients either new discontinued systemic treatment least two month 1 . Morphea profunda systemic scleroderma ( diagnose : Rayaund 's Phenomenon sclerodactyly +/ internal organ affection ) 2 . Contraindications phototherapy : eg : photosensitivity , systemic lupus , melanoma , skin cancer , porphyria . 3 . Contraindications laser : Use systemic retinoids last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Localized scleroderma UVA1 fractional carbon dioxide laser</keyword>
</DOC>